• OPEN AN ACCOUNT
Indian Indices
Sensex
76,957.27 -307.24
( -0.40%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,147.06 -258.50
(-0.39%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Dhariwalcorp Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
93187
INE0YRN01025
6.5259217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DHARIWAL
21.65
185.21
EPS(TTM)
Face Value()
Div & Yield %
0.91
2
0
 

gufic biosciences ltd
Gufic BioSciences consolidated net profit rises 183.68% in the March 2026 quarter
Jun 01,2026
Net profit of Gufic BioSciences rose 183.68% to Rs 21.90 crore in the quarter ended March 2026 as against Rs 7.72 crore during the previous quarter ended March 2025. Sales rose 22.83% to Rs 251.82 crore in the quarter ended March 2026 as against Rs 205.02 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.81% to Rs 64.21 crore in the year ended March 2026 as against Rs 69.65 crore during the previous year ended March 2025. Sales rose 15.15% to Rs 944.01 crore in the year ended March 2026 as against Rs 819.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales251.82205.02 23 944.01819.81 15
OPM %18.7512.87 -16.0316.60 -
PBDT36.6018.37 99 117.38115.21 2
PBT28.9510.52 175 86.5594.14 -8
NP21.907.72 184 64.2169.65 -8